International multicentre retrospective patient-level cohort study

Decompressive craniectomy after aneurysmal subarachnoid hemorrhage.

DECIDE-SAHDEcompressive Craniectomy In SAH: an International Data-Driven Evaluation

DECIDE-SAH studies decompressive craniectomy as a timing-, indication-, severity- and technique-dependent treatment strategy. International centres contribute consecutive historical aSAH cohorts from pre-existing routine-care data.

Retrospective · Observational · Non-interventional · Secondary use of routine-care data

ClinicalTrials.gov · NCT07872774

Participation framework

One study. Three levels of data contribution.

The Minimum Required Dataset (MRD) is the participation threshold. Standard variables should be completed as fully as reliable source data permit; missing individual Standard variables do not by themselves exclude a centre. Optional extensions enable deeper phenotyping. Analysis eligibility is endpoint-specific.

01

MRD — Minimum Required Dataset

Core cohort, baseline, aneurysm-treatment, DC and outcome information. Centres contribute consecutive adult aSAH cohorts—not selected DC cases.

02

Standard Dataset

Adds detailed timing, disease severity, haemorrhage and aneurysm characteristics, treatment course and follow-up outcomes where reliably available.

03

Optional Extension Modules

Deep phenotyping modules cover radiology, ICP, infarction/DCI, DC technique and complications, systemic complications and chronic hydrocephalus.

Scientific rationale

The question is not simply “DC: yes or no”.

Existing evidence is predominantly observational and is affected by confounding by indication, treatment timing, baseline severity, technical heterogeneity and centre-specific practice. DECIDE-SAH therefore evaluates DC in the clinical context in which the decision is made.

The primary objective is to evaluate the association between DC strategy and unfavourable functional outcome at approximately six months, with particular focus on timing, neurological status at the treatment decision, indication and technical characteristics of decompression.

01

When?

Ictus-to-decompression timing; early or pre-emptive versus delayed or rescue strategies.

02

For whom?

Baseline and decision-time neurological status, including severity and herniation signs.

03

Why?

Documented indications: intracerebral haemorrhage, diffuse cerebral oedema, refractory intracranial hypertension, infarction with oedema and other recorded reasons.

04

How?

Type and extent of decompression, technical strategy, redo DC and DC-related complications.

Study registration & ethics

A coordinated international research framework.

Registered international non-interventional retrospective research coordinated by University Hospital Essen.

ClinicalTrials.govNCT07872774 Study registration
University of Duisburg-Essen · Ethics Committee26-13319-BOFavourable opinion · 13 October 2026

International network

Built across borders. Grounded in local governance.

The map shows outreach and replies during network development—not activated study sites. Practice variation is scientifically valuable: centres with high, low or even no DC volume can contribute if they provide consecutive aSAH cohorts.

Global outreach map: countries with contact attempts and countries with documented replies. Germany is the coordinating centre.
Reply receivedContacted · no reply recorded
330centres·111countries / territories

Contacted by the DECIDE-SAH team

137centres·71countries / territories

Documented replies received

Network outreach snapshot: 22 October 2026. Replies are a subset of contacted centres; neither a reply nor an expression of interest constitutes formal site activation.

For interested centres

Participation does not require a perfect database.

The key requirement is a reliable consecutive adult aSAH cohort and the MRD. Centres may contribute their largest reliably available historical cohort; additional Standard variables and extension modules are added according to local availability.

Express interest ↗
  1. Assess feasibilityConfirm a consecutive adult aSAH cohort and review the MRD against locally available data.
  2. Define contribution levelAgree which Standard variables and optional extension modules can be provided reliably.
  3. Complete local approvalsLocal ethics, privacy and data-transfer requirements must be completed before patient-level transfer.

Study documents

Study documents for international collaborators.

Concise reference materials for understanding the study and exploring scientific collaboration. Detailed data-collection materials are provided through direct coordination.

Contact

Expression of interest.

Interested in contributing a consecutive aSAH cohort or discussing feasibility? Contact the coordinating team in Essen. An expression of interest is non-binding; please do not send patient-level data or identifiers by email or through this form.

info@decide-sah.com

Prof. Dr. med. Ramazan Jabbarli
Coordinating Investigator · Department of Neurosurgery and Spine Surgery, University Hospital Essen, Germany.

Send an expression of interest

Information about the processing of contact data

Security verification

The form sends your enquiry to the study team. Do not include patient information. You can also use the email link above.